Ana Júlia Almeida
About Ana Júlia Almeida
Ana Júlia Almeida serves as the Director of Commercial Excellence at Kite Pharma, a position she has held since 2022 in London, England. With extensive experience in market access and regulatory affairs, she has previously worked for notable companies such as Bristol-Myers Squibb and Gilead Sciences.
Work at Kite Pharma
Ana Júlia Almeida currently serves as the Director of Commercial Excellence (ACE) at Kite Pharma, a position she has held since 2022 in London, England. In this role, she focuses on enhancing commercial strategies and operational excellence within the organization. Prior to her current role, she worked as Associate Director of Commercial Learning and Development Lead for ACE, covering regions such as Australia, Canada, and Europe for six months in 2022.
Education and Expertise
Ana Júlia Almeida has a strong educational background in pharmaceutical sciences and health economics. She earned a Master’s Degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Coimbra, which she completed from 2002 to 2008. Additionally, she pursued an MBA at The Lisbon MBA Católica | Nova, graduating in 2021. Her studies also include a Post-Graduation in Economic Evaluation of Medicines from ISEG, and various certifications in Health Economics from the University of York.
Background
Ana Júlia Almeida has extensive experience in the pharmaceutical industry, having worked in various roles across multiple organizations. Her career includes positions at Bristol-Myers Squibb, Gilead Sciences, and Laboratório Edol, where she specialized in market access, regulatory affairs, and pharmacovigilance. She has also contributed to academia as a Visiting Lecturer at the University of Coimbra in 2016.
Previous Positions
Throughout her career, Ana has held several significant positions. At Bristol-Myers Squibb, she worked as Market Access Manager and later as Head of Country Pharmacovigilance in the Medical department. At Gilead Sciences, she served as Senior Market Access Manager and Associate Director of Product Management for Oncology and Cell Therapy. Her early career included a trainee position at GlaxoSmithKline, focusing on market access and pharmacoeconomics.
Professional Development
Ana Júlia Almeida has actively pursued professional development through various educational programs. She completed a Health Technology Assessment MOOC at The University of Sheffield in 2013 and has obtained diplomas in Health Economics from the University of York. These educational experiences have contributed to her expertise in health economics and outcomes research, enhancing her capabilities in the pharmaceutical sector.